Delivery Order SPE2DB22D1103-SPE2DB24FTEU5
Award Date 2/5/24
Potential Completion Date 2/6/24
Potential Value $1.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,097.38 firm fixed price delivery order is for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, with a completion date of February 14, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $23,512.73 firm fixed price delivery order is for the supply of VYVANSE CAPS 50MG, a prescription medication, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,961.80 firm fixed price delivery order is for the supply of 100 units of the medication VYVANSE 10 MG CAPSULE. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a delivery order valued at $1,724.00, is for the provision of 4564214559 VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 9, 2024. This award is not associated...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYVANSE 50 MG CAPSULE 100S. The award, valued at $1,037.99, is a Firm Fixed Price Delivery Order contract with an ultimate completion date of August 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,344.96 firm fixed price delivery order is for the supply of 4,564,135,207 VYVANSE 30 MG CAPSULE 100S to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,587.22 firm fixed price delivery order is for the supply of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,692.75 firm fixed price delivery order is for the supply of VYVANSE 60 MG CAPSULE 100S to support military treatment programs and facilities. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,873.63 firm fixed-price delivery order is for the supply of VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,390.08 Firm Fixed Price Delivery Order is for the supply of 4565403728 - VYVANSE 50 MG CAPSULE 100S, with an ultimate completion date of August 12, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTEU5Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,724.00 firm fixed price delivery order is for VYVANSE 50 MG CAPSULE 100S, with a completion date of February 6, 2024. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Generated 5/6/24, 9:02 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 2/5/24 |